Madhavi M. Lakkaraja

Pediatrics
825 Eastlake Ave E
Seattle, WA 98109

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

ATG Exposure in T Replete Transplant for Hematological Malignancies: Real World Analysis from BMT CTN 1202.

ATG Exposure in T Replete Transplant for Hematological Malignancies: Real World Analysis from BMT CTN 1202.

Journal: Research square
Published: June 29, 2026

ATG Exposure in T Replete Transplant for Hematological Malignancies: Real World Analysis from BMT CTN 1202.

ATG Exposure in T Replete Transplant for Hematological Malignancies: Real World Analysis from BMT CTN 1202.

Journal: Research square
Published: June 29, 2026

Impact Of Conditioning Intensity on Outcomes After Unrelated Donor Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis.

Impact Of Conditioning Intensity on Outcomes After Unrelated Donor Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis.

Journal: Transplantation and cellular therapy
Published: June 21, 2026

Reducing empiric antibiotic administration in pediatric oncology patients with non-neutropenic fever: a single-center quality improvement initiative.

Reducing empiric antibiotic administration in pediatric oncology patients with non-neutropenic fever: a single-center quality improvement initiative.

Journal: Pediatric hematology and oncology
Published: May 07, 2025

Precision transplant and cell therapies for non-malignant disorders-The path forward.

Precision transplant and cell therapies for non-malignant disorders-The path forward.

Journal: British journal of haematology
Published: January 30, 2025

The role of the conditioning regimen for autologous and ex vivo genetically modified hematopoietic stem cell-based therapies: recommendations from the ISCT stem cell engineering committee.

The role of the conditioning regimen for autologous and ex vivo genetically modified hematopoietic stem cell-based therapies: recommendations from the ISCT stem cell engineering committee.

Journal: Cytotherapy
Published: June 28, 2024

Does anti-HPA-1a affect birthweight in fetal and neonatal alloimmune thrombocytopenia?

Does anti-HPA-1a affect birthweight in fetal and neonatal alloimmune thrombocytopenia?

Journal: Pediatric blood & cancer
Published: October 19, 2023

Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell-depleted hematopoietic cell transplantation in pediatric and young adult patients.

Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell-depleted hematopoietic cell transplantation in pediatric and young adult patients.

Journal: Cytotherapy
Published: February 23, 2023

Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant.

Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant.

Journal: Blood
Published: September 28, 2021

Antithymocyte globulin exposure in CD34+ T-cell-depleted allogeneic hematopoietic cell transplantation.

Antithymocyte globulin exposure in CD34+ T-cell-depleted allogeneic hematopoietic cell transplantation.

Journal: Blood advances
Published: June 21, 2021

Management of Chronic Immune Thrombocytopenia and Presumed Autoimmune Hepatitis in a Child with IKAROS Haploinsufficiency.

Management of Chronic Immune Thrombocytopenia and Presumed Autoimmune Hepatitis in a Child with IKAROS Haploinsufficiency.

Journal: Journal of clinical immunology
Published: August 27, 2019

Maternal sensitization occurs before delivery in severe cases of fetal alloimmune thrombocytopenia.

Maternal sensitization occurs before delivery in severe cases of fetal alloimmune thrombocytopenia.

Journal: American journal of hematology
Published: March 09, 2019
Showing 1-12 of 17

Last Updated: 09/26/2026